India has bought 300,000 doses of the Remdesivir drug from Egypt’s Eva Pharma company for drugs and medical supplies, as it grapples with its surging coronavirus pandemic.
The Indian Embassy in Cairo said on Saturday that it would purchase the doses on behalf of the Indian Ministry of Health and Family Welfare. The embassy added in a statement that the agreement will be signed by Ambassador Ajit Gupte and Executive Director of Eva Pharma Riyad Armanious on Monday at the headquarters of the Indian Embassy in Cairo.
Egypt’s Eva Pharma began last year producing Remdesivir, used in the treatment of patients with COVID-19. Remdesivir is indicated for moderate to severe cases of COVID-19 for patients in intensive care who require oxygen.
Eva Pharma, a generic drugmaker established in 1997, said last year it had received a license from Gilead Sciences Inc to make Remdesivir in Egypt and distribute it in 127 countries.
